A Achouri1, C Huchon, A S Bats, C Bensaid, C Nos, F Lécuru. 1. Service de Chirurgie Cancérologique Gynécologique et du Sein, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. abdellaziz.achouri@egp.aphp.fr
Abstract
INTRODUCTION: Symptomatic postoperative lymphocysts (SPOLs) and lower-limb lymphedema (LLL) are probably underestimated complications of lymphadenectomy for gynecologic malignancies. Here, our objective was to evaluate the incidence and risk factors of SPOLs and LLL after pelvic and/or aortocaval lymphadenectomy for gynecologic malignancies. METHODS: Single-center retrospective study of consecutive patients who underwent pelvic and/or aortocaval lymphadenectomy for ovarian cancer, endometrial cancer, or cervical cancer between January 2007 and November 2008. The incidences of SPOL and LLL were computed with their 95% confidence intervals (95%CIs). Multivariate logistic regression was performed to identify independent risk factors for SPOL and LLL. RESULTS: We identified 88 patients including 36 with ovarian cancer, 35 with endometrial cancer, and 17 with cervical cancer. The overall incidence of SPOL was 34.5% (95%CI, 25-45) and that of LLL was 11.4% (95% confidence interval [95%CI], 5-18). Endometrial cancer was independently associated with a lower risk of SPOL (adjusted odds ratio [aOR], 0.09; 95%CI, 0.02-0.44) and one or more positive pelvic nodes with a higher risk of SPOL (aOR, 4.4; 95%CI, 1.2-16.3). Multivariate logistic regression failed to identify factors significantly associated with LLL. CONCLUSION: Complications of lymphadenectomy for gynecologic malignancies are common. This finding supports a more restrictive use of lymphadenectomy or the use of less invasive techniques such as sentinel node biopsy.
INTRODUCTION: Symptomatic postoperative lymphocysts (SPOLs) and lower-limb lymphedema (LLL) are probably underestimated complications of lymphadenectomy for gynecologic malignancies. Here, our objective was to evaluate the incidence and risk factors of SPOLs and LLL after pelvic and/or aortocaval lymphadenectomy for gynecologic malignancies. METHODS: Single-center retrospective study of consecutive patients who underwent pelvic and/or aortocaval lymphadenectomy for ovarian cancer, endometrial cancer, or cervical cancer between January 2007 and November 2008. The incidences of SPOL and LLL were computed with their 95% confidence intervals (95%CIs). Multivariate logistic regression was performed to identify independent risk factors for SPOL and LLL. RESULTS: We identified 88 patients including 36 with ovarian cancer, 35 with endometrial cancer, and 17 with cervical cancer. The overall incidence of SPOL was 34.5% (95%CI, 25-45) and that of LLL was 11.4% (95% confidence interval [95%CI], 5-18). Endometrial cancer was independently associated with a lower risk of SPOL (adjusted odds ratio [aOR], 0.09; 95%CI, 0.02-0.44) and one or more positive pelvic nodes with a higher risk of SPOL (aOR, 4.4; 95%CI, 1.2-16.3). Multivariate logistic regression failed to identify factors significantly associated with LLL. CONCLUSION: Complications of lymphadenectomy for gynecologic malignancies are common. This finding supports a more restrictive use of lymphadenectomy or the use of less invasive techniques such as sentinel node biopsy.
Authors: Jennifer J Mueller; Lawrence T Dauer; Rajmohan Murali; Alexia Iasonos; Neeta Pandit-Taskar; Nadeem R Abu-Rustum; Jan Grimm Journal: J Nucl Med Date: 2020-01-10 Impact factor: 10.057
Authors: Laura R Daily; Jonathan D Boone; Hannah C Machemehl; Eric D Thomas; Gerald McGwin; J Michael Straughn; Charles A Leath Journal: Int J Gynecol Cancer Date: 2017-05 Impact factor: 3.437
Authors: Thomas Papathemelis; Dunja Hassas; Michael Gerken; Monika Klinkhammer-Schalke; Anton Scharl; Michael P Lux; Mathias W Beckmann; Sophia Scharl Journal: J Cancer Res Clin Oncol Date: 2018-07-23 Impact factor: 4.553
Authors: Jvan Casarin; Francesco Multinu; Nadeem Abu-Rustum; David Cibula; William A Cliby; Fabio Ghezzi; Mario Leitao; Ikuo Konishi; Joo-Hyun Nam; Denis Querleu; Pamela T Soliman; Kathleen J Yost; Amy L Weaver; Andrea Mariani; Gretchen E Glaser Journal: Int J Gynecol Cancer Date: 2019-01 Impact factor: 3.437
Authors: A Sahbaz; K Gungorduk; V Gulseren; I A Ozdemir; M Harma; M Harma; M Sancı Journal: Geburtshilfe Frauenheilkd Date: 2016-04 Impact factor: 2.915